Malawi is considering domestic production of drugs to treat sufferers of HIV/Aids, in response to growing concerns about affordable and sustainable supplies of medicine.

Hetherwick Ntabe, Malawi's health minister, said tightened patent legislation in India threatened supplies of antiretroviral (Arv) therapies for the disease. India is a big supplier of generic drugs to the developing world.